Abiomed, Inc. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abiomed with three other
companies in this sector in the United States:
sales of $383.41 million
of which 100%
was Radiosurgery System),
Consort Medical Plc
of which 59%
was Aesica), and
of which 60%
was Peripheral Vascular).
During the year ended March of 2017, sales at
Abiomed were $445.30 million.
increase of 35.1%
versus 2016, when the company's sales were $329.54 million.
This was the fifth consecutive year of sales increases at Abiomed
(and since 2012, sales have increased a total of 252%).